Sustained long-term clinical efficacy and safety in patients with psoriasis for up to 2.5 years on etanercept

被引：0
|
作者：
Serban, Anca
Elewski, Boni
Leonardi, Craig
Gottlieb, Alice
Strober, Bruce
van der Kerkhof, Peter C. M.
Ortonne, Jean Paul
机构：
[1] Wyeth Ayerst Res, Collegeville, PA USA
[2] Univ Alabama, Birmingham, AL USA
[3] St Louis Univ, St Louis, MO 63103 USA
[4] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, New Brunswick, NJ USA
[5] Johns Hopkins Univ, New York, NY USA
[6] Univ Nijmegen Hosp, NL-6500 HB Nijmegen, Netherlands
[7] Hosp Archet, Nice, France
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2007年 / 127卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
64
引用
收藏
页码：1813 / 1813
页数：1
相关论文
共 50 条
  • [41] Long-term Efficacy and Safety of Siponimod in Patients with SPMS: EXPAND Extension Analysis Up to 5 Years
    Kappos, Ludwig
    Giovannoni, Gavin
    Gold, Ralf
    Fox, Robert J.
    Vermersch, Patrick
    Benedict, Ralph H. B.
    Bar-Or, Amit
    Rouyrre, Nicolas
    Meier, Daniela Piani
    Ritter, Shannon
    Kilaru, Ajay
    Dahlke, Frank
    Karlsson, Goeril
    Cree, Bruce A. C.
    NEUROLOGY, 2020, 94 (15)
  • [42] Safety and efficacy study on etanercept in patients with plaque psoriasis
    Costanzo, A
    Mazzotta, A
    Papoutsaki, M
    Chimenti, S
    BRITISH JOURNAL OF DERMATOLOGY, 2005, 152 (01) : 187 - 189
  • [43] Efficacy and safety of etanercept in patients with psoriasis and hepatitis C
    Ventura, Filipa
    Gomes, Joana
    Duarte, Maria da Luz
    Fernandes, Jose Carlos
    Brito, Celeste
    EUROPEAN JOURNAL OF DERMATOLOGY, 2010, 20 (06) : 808 - 809
  • [44] Sustained long-term efficacy and safety of inhaled insulin during 4 years of continuous therapy
    Skyler, J
    DIABETES, 2004, 53 : A115 - A115
  • [45] Long-term, sustained efficacy, and safety of inhaled insulin after 4 years of continuous therapy
    Skyler, JS
    DIABETOLOGIA, 2004, 47 : A311 - A311
  • [46] The long-term efficacy and safety of new biological therapies for psoriasis
    Kim A. Papp
    Archives of Dermatological Research, 2006, 298 : 7 - 15
  • [47] The long-term efficacy and safety of new biological therapies for psoriasis
    Papp, KA
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2006, 298 (01) : 7 - 15
  • [48] Long-term safety of ustekinumab: 5 years of follow-up from the psoriasis clinical development program including patients with psoriatic arthritis
    Papp, K.
    Griffiths, C. E. M.
    Gordon, K.
    Lebwohl, M.
    Szapary, P. O.
    Wasfi, Y.
    Chan, D.
    Shen, Y. K.
    Ho, V.
    Ghislain, P. D.
    Strober, B.
    Reich, K.
    SWISS MEDICAL WEEKLY, 2014, 144 : 5S - 5S
  • [49] Long-term safety of ustekinumab: 5 years of follow-up from the psoriasis clinical development program including patients with psoriatic arthritis
    Papp, Kim
    Reich, Kristian
    Lebwohl, Mark
    Wasfi, Yasmine
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (05) : AB174 - AB174
  • [50] LONG-TERM SAFETY OF USTEKINUMAB: 5 YEARS OF FOLLOW-UP FROM THE PSORIASIS CLINICAL DEVELOPMENT PROGRAM INCLUDING PATIENTS WITH PSORIATIC ARTHRITIS
    Papp, K.
    Griffiths, C.
    Gordon, K.
    Lebwohl, M.
    Szapary, P. O.
    Wasfi, Y.
    Chan, D.
    Shen, Y. K.
    Ho, V.
    Ghislain, P. D.
    Strober, B.
    Reich, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 680 - 680
12345